0000950138-20-000132.txt : 20200303
0000950138-20-000132.hdr.sgml : 20200303
20200303175428
ACCESSION NUMBER: 0000950138-20-000132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200301
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urbanek David Alan
CENTRAL INDEX KEY: 0001752446
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 20684322
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-03-01
0001739104
Elanco Animal Health Inc
ELAN
0001752446
Urbanek David Alan
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
0
1
0
0
See Remarks
Common Stock
2020-03-01
4
F
0
425
27.40
D
60734
D
Common Stock
2020-03-02
4
A
0
6678
0
A
67412
D
Common Stock
76
I
By son
Common Stock
76
I
By daughter
Common Stock
76
I
By son
Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan.
Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023.
Executive Vice President, Manufacturing and Quality
/s/ Darlene Quashie Henry, as Attorney-in-Fact for David A. Urbanek
2020-03-03